Impact of surgical volume on functional results and cardiospecific survival rates in patients with clinically localized renal cancer

Objective: to analyze the impact of surgical volume on functional results and cardiospecific survival rates in patients with clinically localized renal carcinoma.

Subjects and methods. Four hundred and fifty-three patients with pT1–3aN0M0 renal cell carcinoma and normally functioning second
kidney who had undergone radical nephrectomy (n = 226 (49.9 %)) or kidney resection (n = 227 (50.1 %)) were selected for the investigation. The patient groups who had undergone different-volume operations were matched for gender, age, body mass index (BMI), side of involvement, tumor sizes, and baseline glomerular filtration rate (GFR) (p > for all). The median baseline Charlson index and the rate of ASA classes III–IV operative risk were significantly higher in candidates for radical nephrectomy (p < 0.05 for all), the rate of diseases affecting kidney function, pT1a category, and G1 anaplasia were higher in the kidney resection group (p < 0.0001). The median follow-up was 50 (12–224) months.

Results. Within 28 days postsurgery, the rate of acute renal dysfunction (ARD) was 36.2 %. The independent risk factors of ARD were kidney resection (risk ratio (RR) = 0.210; 95 % confidence interval (CI) 0.115–0.288; р < 0.0001) and ischemia time (RR = 0.012; 95 % CI 0.004–0.021; p = 0.004). The degree of ARD after kidney resection was significantly lower than that following radical nephrectomy (p < 0.0001). In the late postoperative period, the incidence of chronic kidney disease (CKD) Stage ≥ III was 38.4 %. Its independent risk factors were low baseline GFR (RR = 0.003; 95 % CI 0.002–0.005; p < 0.0001), radical nephrectomy (RR = 0.195; 95 % CI 0.093–0.298; p < 0.0001), and ARD (RR = 0.281; 95 % CI 0.187–0.376; p = 0.0001). Ten-year specific and cardiospecific survival rates in all the patients were 98.5 and 94.9 %, respectively, and unrelated to surgical volume. The independent predictors of poor cardiospecific survival were BMI, Charlson index, and ASA risk. No relationship was found betwen cardiospecific survival and GFR in the late postoperative period.

Conclusion. Kidney resection versus radical nephrectomy significantly increases the risk of severe ARD. The scope of surgical treatment for clinically localized renal cancer has not been found to affect cardiospecific survival.

1. Алексеев Б.Я., Русаков И.Г., Поляков В.А. и др. Лапароскопическая резекция почки. Рос онкол журн 2006;6:16–20.

2. Tait C., Tandon S., Baker L. et al. Longterm oncologic outcomes of laparoscopic radical nephrectomy for kidney cancer resection: Dundee cohort and metaanalysis of observational studies. Surg Endosc 2011;25(10):3154–61.

3. Tan H.-J., Norton E.C., Ye Z. et al. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 2012;307(15):1629–35.

4. Van Poppel H., L. Da Pozzo, W. Albrecht et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59: 543–52.

5. Shlipak M.G., Smith G.L., Rathore S.S. et al. Renal function, digoxin therapy, and heart failure outcomes: Evidence from the digoxin intervention group trial. J Am Soc Nephrol 2004;15:2195–203.

6. Weight C.J., Lieser G., Larson B.T. et al. Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol 2010;58: 293–8.

7. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:1–266.

8. Bellomo R., Ronco C., Kellum J.A. et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 Aug;8(4):R204–12.

9. Motzer R.J., Agarwal N., Beard C. et al. NCCN clinical practice guidelines in oncology: kidney сancer. J Natl Cancer Netw 2009;7:618.

10. Campbell S.C., Novick A.C., Belldegrun A. et al. Guideline for management of the clinical T1 renal mass. J Urol 2009;182:1271.

11. Ljungberg B., Cowan N.C., Hanbury D.C. et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010;58:398.

12. Kim S. P., Thompson R.H., Boorjian S.A. et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012;188:51–7.

13. Weight C.J., Lieser G., Larson B.T. et al. Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol 2010;58: 293–8.

14. Klarenbach S., Moore R.B., Chapman D.W. et al. Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis. Eur Urol 2011;59:333–9.

15. Knight S., Johns E.J. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation. Clin Exp Pharmacol Physiol 2008;35(1):11–6.

16. Barlow L., Korets R., Laudano M. et al. Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis. BJU Int 2010;106: 489–92.

17. Weinstein J.R., Anderson S. The aging kidney: physiological changes. Adv Chronic Kidney Dis 2010;17(4):302–7.

18. Huang W.C., Levey A.S., Serio A.M. et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol 2006;7:735–40.

19. Jeon H.G., Jeong I.G., Lee J.W. et al. Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors. Urology 2009;74:1064–8.

20. Jeldres C., Bensalah K., Capitanio U. et al. Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy. BJU Int 2009;103: 1632–5.

21. Cho A., Lee J.E., Kwon G.Y. et al. Postoperative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy. Nephrol Dial Transplant 2011; 26(11):3496–501.

22. Prassopoulos P., Cavouras D., Gourtsoyiannis N. Pre- and post-nephrectomy kidney enlargement in patients with contralateral renal cancer. Eur Urol 1993;24:58–61.

23. Okusa M.D., Chertow G.M., Portilla D. The nexus of acute kidney injury, chronic kidney disease, and World Kidney Day 2009. Clin J Am Soc Nephrol 2009;4:520–2.

24. Lo L.J., Go A.S., Chertow G.M. et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 2009;76:893–9.

25. Burne-Taney M.J., Liu M., Ascon D. et al. Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in naive mice: a possible mechanism linking early injury and progressive renal disease? Am J Physiol Renal Physiol 2006;291:981–6.

26. Burne-Taney M.J., Yokota N., Rabb H. Persistent renal and extrarenal immune changes after severe ischemic injury. Kidney Int 2005;67:1002–9.

27. Basile D.P., Donohoe D., Roethe K. et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001;281:887–99.

28. Horbelt M., Lee S.Y., Mang H.E. et al. Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol Renal Physiol 2007;293:688–95.

29. Brenner B.M. Nephron adaptation to renal injury of ablation. Am J Physiol 1985;249: 324–37.

30. McKiernan J., Simmons R., Katz J., Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002;59:816–20.

31. Lau W.K., Blute M.L., Weaver A.L. et al. Matched comparison of radical nephrectomy vs nephron sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000;75: 1236–42.

32. Miller D.C., Schonlau M., Litwin M.S. et al. Urologic Diseases in America Project. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer 2008;112(3):511–20.

33. Klasen J., Junger A., Hartmann B. et al. Increased body mass index and peri-operative risk in patients undergoing non-cardiac surgery. Obes Surg 2004;14(2):275–81.